{"filing":{"accession_number":"0001437749-26-027829","cik":"0001019034","ticker":"BKYI","company_name":"BIO KEY INTERNATIONAL INC","form":"8-K","filing_date":"2026-08-14","report_date":"2026-08-13","primary_document":"bkyi20260813c_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774926027829/bkyi20260813c_8k.htm"},"events":[{"id":27747,"run_id":25321,"accession_number":"0001437749-26-027829","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"This is a clear earnings release disclosing Q2 2026 and 1H 2026 financial results for BIO-key International. The press release (Exhibit 99.1) announces revenues of $1.9M in Q2'26 (up 13% YoY), gross margin improvement to 87%, and a 51% reduction in net loss to $(577K). The filing is made under Item 2.02 (Results of Operations and Financial Condition) and includes detailed financial statements and management commentary on performance and outlook.","company_name":"BIO KEY INTERNATIONAL INC","ticker":"BKYI","filing_date":"2026-08-14","form":"8-K","submitted_at":null,"items":[{"id":29412,"accession_number":"0001437749-26-027829","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release disclosing Q2 2026 and 1H 2026 financial results for BIO-key International. The press release (Exhibit 99.1) announces revenues of $1.9M in Q2'26 (up 13% YoY), gross margin improvement to 87%, and a 51% reduction in net loss to $(577K). The filing is made under Item 2.02 (Results of Operations and Financial Condition) and includes detailed financial statements and management commentary on performance and outlook.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T12:04:11.317479+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":29412,"accession_number":"0001437749-26-027829","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"This is a clear earnings release disclosing Q2 2026 and 1H 2026 financial results for BIO-key International. The press release (Exhibit 99.1) announces revenues of $1.9M in Q2'26 (up 13% YoY), gross margin improvement to 87%, and a 51% reduction in net loss to $(577K). The filing is made under Item 2.02 (Results of Operations and Financial Condition) and includes detailed financial statements and management commentary on performance and outlook.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-14T12:04:11.317479+00:00","company_name":"BIO KEY INTERNATIONAL INC","ticker":"BKYI","filing_date":"2026-08-14"}]}